image:
Study shows that cardiac spheroids, derived from human induced pluripotent stem cells, can be easily transported and injected into damaged areas of the heart to promote its regeneration and recovery of function.
Credit: Hideki Kobayashi from Shinshu University
Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high. In a recent study, researchers from Japan tested a novel approach that involves injecting cardiac spheroids, cultured from human stem cells, directly into damaged ventricles. The highly positive outcomes observed in primate models highlight the potential of this strategy.
Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent in developed countries. Myocardial infarctions, commonly known as heart attacks, are on the rise, resulting in a significant number of deaths each year.
Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure. Given that full heart transplants are expensive and donors difficult to come by, it is no surprise that alternative therapies are highly sought after by the medical community.
One promising strategy that has been steadily gaining traction is using human induced pluripotent stem cells (HiPSCs) for regenerative heart therapy. Simply put, HiPSCs are cells derived from mature cells that can be effectively reprogrammed into a completely different cell type, such as cardiac muscle cells (cardiomyocytes). By transplanting or injecting cardiomyocytes derived from HiPSCs into damaged areas of the heart, it is possible to recover some lost functionality. Unfortunately, studies have reported that this approach can increase the risk of arrythmias, posing a major hurdle to clinical trials.
In a recent study, a Japanese research team from Shinshu University and Keio University School of Medicine, tested a new strategy for regenerative heart therapy that involves injecting cardiac spheroids derived from HiPSCs into monkeys with myocardial infarction. This study, published on April 26, 2024, in the journal Circulation, was led by Professor Yuji Shiba from the Department of Regenerative Science and Medicine, Shinshu University.
The team included Hideki Kobayashi, the first author, and Koichiro Kuwahara from the Department of Cardiovascular Medicine, Shinshu University School of Medicine, as well as Shugo Tohyama, and Keiichi Fukuda from the Department of Cardiology, Keio University School of Medicine, among others.
In their novel approach, the researchers cultivated HiPSCs in a medium that led to their differentiation into cardiomyocytes. After carefully extracting and purifying cardiac spheroids (three-dimensional clusters of cardiac cells) from the cultures, they injected approximately 6 107 cells into the damaged hearts of crab-eating macaques (Macaca fascicularis). They monitored the condition of the animals for twelve weeks, taking regular measurements of cardiac function. Following this, they analyzed the monkeys hearts at the tissue level to assess whether cardiac spheroids could regenerate the damaged heart muscles.
First, the team verified the correct reprogramming of HiPSCs into cardiomyocytes. They observed, via cellular-level electrical measurements, that the cultured cells exhibited potential patterns typical of ventricular cells. The cells also responded as expected to various known drugs. Most importantly, they found that the cells abundantly expressed adhesive proteins such as connexin 43 and N-cadherin, which would promote their vascular integration into an existing heart.
Afterwards, the cells were transported from the production facility at Keio University to Shinshu University, located 230 km away. The cardiac spheroids, which were preserved at 4 C in standard containers, withstood the four-hour journey without problem. This means that no extreme cryogenic measures would be needed when transporting the cells to clinics, which would make the proposed approach less expensive and easier to adopt.
Finally, the monkeys received injections of either cardiac spheroids or a placebo directly into the damaged heart ventricle. During the observation period, the researchers noted that arrythmias were very uncommon, with only two individuals experiencing transient tachycardia (fast pulse) in the first two weeks among the treatment group. Through echocardiography and computed tomography exams, the team confirmed that the hearts of monkeys that received treatment had better left ventricular ejection after four weeks compared to the control group, indicating a superior blood pumping capability.
Histological analysis ultimately revealed that the cardiac grafts were mature and properly connected to pre-existing existing tissue, cementing the results of previous observations. HiPSC-derived cardiac spheroids could potentially serve as an optimal form of cardiomyocyte products for heart regeneration, given their straightforward generation process and effectiveness, remarks Assistant Professor Kobayashi. We believe that the results of this research will help solve the major issue of ventricular arrhythmia that occurs after cell transplantation and will greatly accelerate the realization of cardiac regenerative therapy, he further adds.
Although tested in monkeys, it is worth noting that the cardiac spheroid production protocol used in this study was designed for clinical application in humans. The favorable results obtained thus far are sufficient to provide a green light for our clinical trial, called the LAPiS trial. We are already employing the same cardiac spheroids on patients with ischemic cardiomyopathy, comments Asst. Prof. Kobayashi.
Let us all hope for a resounding success in the LAPiS trial, paving the way for expanded and effective treatment avenues for people suffering from heart problems.
###
About Shinshu University
Shinshu Universityis a national university founded in 1949 and located nestling under the Japanese Alps in Nagano known for its stunning natural landscapes. Our motto, "Powered by Nature - strengthening our network with society and applying nature to create innovative solutions for a better tomorrow" reflects the mission of fostering promising creative professionals and deepening the collaborative relationship with local communities, which leads to our contribution to regional development by innovation in various fields. Were working on providing solutions for building a sustainable society through interdisciplinary research fields: material science (carbon, fiber and composites), biomedical science (for intractable diseases and preventive medicine) and mountain science, and aiming to boost research and innovation capability through collaborative projects with distinguished researchers from the world. For more information visit https://www.shinshu-u.ac.jp/english/ or follow us on X (Twitter) @ShinshuUni for our latest news.
About Assistant Professor Hideki Kobayashi
Prof. Hideki Kobayashi became a faculty member at Shinshu University Graduate School of Medicine in 2017, focusing his expertise in cardiology and cardiac electrophysiology. With a prolific publication record, he has contributed to over 25 papers in these fields. His professional affiliations include membership in esteemed organizations such as the Japan Society of Internal Medicine, the Japan Circulation Society, the Japanese Heart Rhythm Society and the International Society of Cardiology Research.
About Professor Yuji Shiba
Prof. Yuji Shiba obtained MD and PhD degrees from Shinshu University in 1998 and 2007, respectively, and has remained closely affiliated with the institution throughout his career. Since 2017, he has been a full Professor at the Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research at Shinshu University. His research endeavours primarily focus on cardiac regeneration using stem cells, an emerging biotechnological field. He has published over 45 papers on these topics, as well as over 10 books and book chapters. He is a member of the Japan Society of Internal Medicine and the Japan Circulation Society.
Experimental study
Animals
Regeneration of non-human primate hearts with human induced pluripotent stem cell-derived cardiac spheroids
26-Apr-2024
The authors have no competing interests to declare.
Excerpt from:
Using stem cell-derived heart muscle cells to advance heart regenerative therapy - EurekAlert
- Cardiac Regeneration - Center for Regenerative Medicine - Mayo Clinic ... [Last Updated On: April 11th, 2018] [Originally Added On: April 11th, 2018]
- Cardiac Regeneration - Mayo Clinic [Last Updated On: April 22nd, 2018] [Originally Added On: April 22nd, 2018]
- Materials - MDPI [Last Updated On: May 18th, 2018] [Originally Added On: May 18th, 2018]
- Cardiac Stem Cell Research - Cedars-Sinai [Last Updated On: May 22nd, 2018] [Originally Added On: May 22nd, 2018]
- Cardiac regeneration: current therapiesfuture concepts ... [Last Updated On: May 26th, 2018] [Originally Added On: May 26th, 2018]
- Cardiac Regeneration - Victor Chang Cardiac Research Institute [Last Updated On: May 30th, 2018] [Originally Added On: May 30th, 2018]
- Cardiology Conferences | Cardio 2018 Events | Cardiac ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Laboratory for Cardiac Regeneration | Baylor College of ... [Last Updated On: June 18th, 2018] [Originally Added On: June 18th, 2018]
- Regeneration of Muscle [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- Regeneration of Muscle - eLS: Essential for Life Science [Last Updated On: July 14th, 2018] [Originally Added On: July 14th, 2018]
- Cardiac Repair and Regeneration Research Unit | Heart and ... [Last Updated On: July 25th, 2018] [Originally Added On: July 25th, 2018]
- Myogenesis - Wikipedia [Last Updated On: August 8th, 2018] [Originally Added On: August 8th, 2018]
- Regeneration (biology) - Wikipedia [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- World Cardiology and Cardiologist Meeting [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Cardiac (comics) - Wikipedia [Last Updated On: August 26th, 2018] [Originally Added On: August 26th, 2018]
- Cardiac regeneration and repair - 1st Edition - Elsevier [Last Updated On: September 21st, 2018] [Originally Added On: September 21st, 2018]
- Post-doc position available cardiac regeneration ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- UW Bioengineering: Building World Leadership in Heart ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- Cardiac Regeneration - What Science Can Do - AstraZeneca [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Cardiac Regeneration, Stem Cells | Research | Baylor ... [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Cardiac Regeneration - Victor Chang Institute [Last Updated On: December 6th, 2018] [Originally Added On: December 6th, 2018]
- Entering a new era in vascular and cardiac regeneration ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac regeneration and repair - 1st Edition [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Heart Regeneration Technologies [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac Regeneration - Center for Regenerative Medicine ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Zebrafish Heart Regeneration | HHMI BioInteractive [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Rapid cell regeneration - Heroes Wiki [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Cardiac muscle - Wikipedia [Last Updated On: December 23rd, 2018] [Originally Added On: December 23rd, 2018]
- Cardiac regeneration in and : discrepancies and problems ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- OHSU Center for Regenerative Medicine Heart Regeneration ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- Dr. Sanjiv Dhingra, Cardiac Regeneration and Tissue ... [Last Updated On: January 30th, 2019] [Originally Added On: January 30th, 2019]
- Mending a Broken Heart: Stem Cells and Cardiac Repair ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Cardiac Repair and Regeneration | Division of Cardiology ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Stem Cell Therapy and Stem Cell Injection Provider Finder ... [Last Updated On: March 5th, 2019] [Originally Added On: March 5th, 2019]
- KearnsSayre syndrome - Wikipedia [Last Updated On: March 8th, 2019] [Originally Added On: March 8th, 2019]
- Ruohola-Baker Lab [Last Updated On: March 15th, 2019] [Originally Added On: March 15th, 2019]
- MTS Science [Last Updated On: May 3rd, 2019] [Originally Added On: May 3rd, 2019]
- New Insights Into the Healing Capacity of the Heart: The Hippo Pathway - Cath Lab Digest [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- The nanoengineer working to mend broken hearts - UNSW Newsroom [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- New insights into heart's healing capacity - Baylor College of Medicine News [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- Tenaya Therapeutics Closes $92 Million Series B Financing - BioSpace [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Regenerative medicine today: Are diabetes and vascular disease treatments ready for the clinic? - Science Magazine [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Reviewing resTORbio Inc. (TORC)'s and Anika Therapeutics Inc. (NASDAQ:ANIK)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- TAMassociati: the new Church of the Resurrection in Varignano - Floornature.com [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- What the Hippo pathway in cardiac fibroblasts reveals about heart function - Baylor College of Medicine News [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD) - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Regenerative Medicine Market Industry Outlook, Growth Prospects and Key Opportunities - Health News Office [Last Updated On: October 24th, 2019] [Originally Added On: October 24th, 2019]
- Ottawa-based treatment a leap forward in addressing heart failure - Winnipeg Sun [Last Updated On: October 27th, 2019] [Originally Added On: October 27th, 2019]
- Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -... [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure - Physician's Weekly [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- SANUWAVE Health Reports Third Quarter 2019 Financial Results Other OTC:SNWV - GlobeNewswire [Last Updated On: November 16th, 2019] [Originally Added On: November 16th, 2019]
- Moderna: Undervalued As The Promising Pipeline Awaits Collaborations - Seeking Alpha [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells Derived from Adipose Tissue and Bone Marrow on Acute Myocardial Infarction... [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania [Last Updated On: December 5th, 2019] [Originally Added On: December 5th, 2019]
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace [Last Updated On: December 9th, 2019] [Originally Added On: December 9th, 2019]
- Polymeric Biomaterials Market Trends Analysis Forecast to 2019-2024 |Evolving Industry Overview by Types, Applications, Size & Share - Sino News... [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- SMD - Researchers look behind the biological curtain on how fish oil might fight inflammatory disease - QMUL [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- Suspended animation, you say? The biggest and freakiest scientific breakthroughs of 2019 - SYFY WIRE [Last Updated On: December 29th, 2019] [Originally Added On: December 29th, 2019]
- 2019: Year in Pictures by Robert Cohen | Metro - STLtoday.com [Last Updated On: December 31st, 2019] [Originally Added On: December 31st, 2019]
- MicroCures Announces Issuance of New Patent Covering First-of-its-Kind Cell Movement Decelerator Technology with Potential Applications in Oncology... [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Cells that regenerate heart in zebrafish discovered - Biology Reporter [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- SANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors - Yahoo Finance [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - Associated Press [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Researchers and Doctors alike pursuing the field of stem cell research in treating heart attack survivors - Medical Herald [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Artificial Heart Lung Machines Market report reviews opportunities and analysis by size, share, trends, manufacturer, forecast 2020-2026 - WhaTech... [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Scientists have figured out how to make the heart to regenerate - The Times Hub [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat dietinduced obesity - Science Advances [Last Updated On: May 9th, 2020] [Originally Added On: May 9th, 2020]
- SANUWAVE HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020 - Yahoo Finance [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020 - Yahoo Finance [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]
- SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity's UltraMIST and Exclusive Partnership Rights for Wound Care Biologic... [Last Updated On: June 11th, 2020] [Originally Added On: June 11th, 2020]
- SANUWAVE Health, Inc. Discusses The Potential of Their Celularity Acquisition with The Stock Day Podcast (SNWV) July 1, 2020 - Stock Day Media [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Interim Analysis of Recardio's Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology - PRNewswire [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Growth and demand of Plasma Therapy in the Asia Pacific Region available in the latest report - WhaTech Technology and Markets News [Last Updated On: July 4th, 2020] [Originally Added On: July 4th, 2020]
- Plasma Therapy Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2027 - Bulletin Line [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen for Vascular Repair - BioSpace [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Polymeric Biomaterials Market Insights by Current Trends 2020 Future Demand by Top Key Players, Regions, Industry Size, and Business Strategy... [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- CORRECTION - SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S. - Stockhouse [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- New Research Paper Suggests RegeneRx's Thymosin Beta 4 May be Useful in Treating COVID-19 - PRNewswire [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]